Mucosal immunisation of African green monkeys ( Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
Open Access
- 1 June 2004
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 363 (9427), 2122-2127
- https://doi.org/10.1016/s0140-6736(04)16501-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Effects of Human Metapneumovirus and Respiratory Syncytial Virus Antigen Insertion in Two 3′ Proximal Genome Positions of Bovine/Human Parainfluenza Virus Type 3 on Virus Replication and ImmunogenicityJournal of Virology, 2003
- SARS virus infection of cats and ferretsNature, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Koch's postulates fulfilled for SARS virusNature, 2003
- Recombinant Bovine/Human Parainfluenza Virus Type 3 (B/HPIV3) Expressing the Respiratory Syncytial Virus (RSV) G and F Proteins Can Be Used To Achieve Simultaneous Mucosal Immunization against RSV and HPIV3Journal of Virology, 2001
- Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infantsThe Pediatric Infectious Disease Journal, 1996
- A Live Human Parainfluenza Type 3 Virus Vaccine Is Attenuated and Immunogenic in Healthy Infants and ChildrenThe Journal of Infectious Diseases, 1995
- Immunogenicity of the S protein of transmissible gastroenteritis virus expressed in baculovirusArchiv für die gesamte Virusforschung, 1994
- A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSVVaccine, 1993
- Antibody-mediated enhancement of disease in feline infectious peritonitis: Comparisons with dengue hemorrhagic feverComparative Immunology, Microbiology and Infectious Diseases, 1981